Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (531-540 of 625) with videos related to

Pageof 63
Sort By:
Annals of the Rheumatic Diseases|February 16, 2023
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposingLourdes Ortiz-Fernández, Elio G Carmona, Martin Kerick, et al.
Frontiers in Pharmacology|January 11, 2020
Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective StudySalvatore D'Angelo, Fabrizio Cantini, Roberta Ramonda, et al.
Plos One|December 27, 2018
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibilityDavid González-Serna, Elio G Carmona, Norberto Ortego-Centeno, et al.
Acta Bio-Medica : Atenei Parmensis|August 4, 2023
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literatureLuca Magnani, Alarico Ariani, Andrea Lo Monaco, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab in patients with severe COVID-19: a retrospective cohort studyGiovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, et al.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Frontiers in Pharmacology|September 12, 2019
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Donato Rigante, Piero Ruscitti, et al.
Nature Reviews. Rheumatology|May 10, 2023
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitisGiacomo Emmi, Alessandra Bettiol, Elena Gelain, et al.
Annals of the Rheumatic Diseases|February 24, 2023
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumaticaChristian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, et al.
Pageof 63

Showing results (531-540 of 625) with videos related to

Sort By:
Pageof 63
Annals of the Rheumatic Diseases|February 16, 2023
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposingLourdes Ortiz-Fernández, Elio G Carmona, Martin Kerick, et al.
Frontiers in Pharmacology|January 11, 2020
Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective StudySalvatore D'Angelo, Fabrizio Cantini, Roberta Ramonda, et al.
Plos One|December 27, 2018
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibilityDavid González-Serna, Elio G Carmona, Norberto Ortego-Centeno, et al.
Acta Bio-Medica : Atenei Parmensis|August 4, 2023
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literatureLuca Magnani, Alarico Ariani, Andrea Lo Monaco, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab in patients with severe COVID-19: a retrospective cohort studyGiovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, et al.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Frontiers in Pharmacology|September 12, 2019
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Donato Rigante, Piero Ruscitti, et al.
Nature Reviews. Rheumatology|May 10, 2023
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitisGiacomo Emmi, Alessandra Bettiol, Elena Gelain, et al.
Annals of the Rheumatic Diseases|February 24, 2023
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumaticaChristian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, et al.
Pageof 63